For designated persons at a listed company, "I didn't actually know anything price-sensitive" is not a defense during a closed trading window — the restriction applies to the calendar period itself, regardless of an individual's actual knowledge at the time.
Listed companies are required to close the trading window for designated persons during periods when Unpublished Price Sensitive Information (UPSI) is reasonably expected to exist — the most predictable and recurring instance being the period around quarterly financial results:
Beyond the quarterly results cycle, the trading window is also closed during other specific UPSI events as they arise — a pending material acquisition, a proposed restructuring, or other significant corporate developments not yet publicly disclosed.
Designated persons — a list each listed company is required to identify and maintain, typically including promoters, directors, key managerial personnel, and other employees whose role gives them regular or potential access to UPSI — are barred from trading in the company's securities during closed window periods. Companies often extend this restriction to immediate relatives of designated persons as well, given the risk of UPSI being shared within a household.
Many companies additionally require designated persons to obtain pre-clearance from a compliance officer before executing any trade, even during an open trading window, once the transaction value crosses a specified threshold — this gives the company a further checkpoint to catch any situation-specific UPSI concern that might not be captured by the standard closed-window calendar alone.
SEBI's framework also generally requires designated persons to hold securities acquired for a minimum period (commonly six months) before selling — intended to discourage the kind of short-term, opportunistically-timed trading around UPSI events that the broader insider trading framework is designed to prevent, even for trades executed during an open window.
Trading in violation of the closed trading window — even without proof the individual actually possessed or used specific UPSI — is treated as a serious compliance violation, typically triggering internal disciplinary action by the company, mandatory disclosure to the stock exchange, and potential SEBI enforcement action, since the closed-window rule itself is designed to be a bright-line, strict compliance requirement rather than a case-by-case judgment call.
Use the current official instrument, portal or regulator publication before acting. This panel separates the category authority from page-specific references.
The prior page did not embed a page-specific external source. The category authority above is the minimum verification starting point; a specific instrument should be added during the next substantive editorial review.